SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from American Heart Association Scientific Meeting-Reference-Cited by-同舟云学术

SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from American Heart Association Scientific Meeting

Published:2023-12-07 Issue: Volume: Page:
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Kato Eri Toda¹²^ORCID,Ono Koh³^ORCID,Lewis Basil S⁴^ORCID

Affiliation:

1. D , Kyoto , Japan

2. epartment of Cardiovascular Medicine and Department of Clinical Laboratory Department, Kyoto University Hospital , Kyoto , Japan

3. Department of Cardiovascular Medicine, Kyoto University Hospital , Kyoto , Japan

4. Ruth and Bruce Rappaport School of Medicine of the Technion, Israel Institute of Technology , 3525433 Haifa , Israel

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/ehjcvp/advance-article-pdf/doi/10.1093/ehjcvp/pvad099/55114990/pvad099.pdf

Reference7 articles.

1. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure;Mcdonagh;Eur Heart J,2023

2. What is new in the 2023 AHA/ACC multisociety guideline on chronic coronary disease?;Gragnano;Eur Heart J Cardiovasc Pharmacother,2023

3. Are SGLT2 inhibitors effective against ‘all’ heart failure with preserved ejection fraction?;Hasegawa;Eur Heart J Cardiovasc Pharmacother,2022

4. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med,2019

5. Dapagliflozin and cardiovascular outcomes in patients with type 2 diabetes mellitus and previous myocardial infarction;Furtado;Circulation,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of sodium–glucose cotransporter 2 inhibitors in post-myocardial infarction management: insights from EMPACT-MI and DAPA-MI trials;European Heart Journal - Cardiovascular Pharmacotherapy;2024-07-10